cannabis industry
cannabis industry · page 94
- Medical
Panaxia agreement to bring medical cannabis products into Germany
The products are currently being used in Israel for oncology patients for cancer pain, loss of appetite and other side effects related to cancer treatments.
- CBD Market
Report explores cannabis regulations of North America and Europe
The first-of-its-kind report from New Frontier Data says that years of prohibition and an international illicit market have presented distinct challenges for legal markets.
- CBD Market
Peakbirch acquisition of Stul to accelerate cannabis sales to UK
Peakbirch Logic has acquired Stul Ltd and its ‘Hot Box Herb’ brand in a move that will accelerate its goal to expand cannabis sales to the UK.
- Medical
A new frontier in medicine: MGC Pharma discusses drug delivery innovation
MGC Pharma is hoping to bring more surprises to the market in the next few years.
- Pharmaceutical
Oxford Cannabinoid Technologies secures drug development agreements
The agreements follow its post-IPO review after its £16.5m fundraise and admission to the main market on LSE in May this year.
- CBD Market
Paul Finnegan discusses 300 per cent growth of CBD brand Naturecan
CBD brand Naturecan has grown substantially over just a short period and seen record growth of 300 per cent over the last 12 months.
- Medical
Supply chains urged to use authentication to protect cannabis products
The IHMA says counterfeit cannabis is an alarming development that sees criminals taking advantage of people in desperate need of products.
- CBD Market
Sales surge puts Love Hemp on road to global expansion
Love Hemp expects further growth this year amid its launch on Amazon in Q1 2022, a new subscription model and overseas expansion in the US, Europe and Japan.
- CBD Market
Protest calls for farmers to ‘grow hemp without a licence’
Hempen is encouraging cultivators to grow hemp without a licence as applications can be refused for simple issues such as the farm being near a road or public footpath
- Medical
Patent for THC as Alzheimer’s treatment granted to India Globalization
India Globalization hopes the formula could provide relief for the potential 50 million people across the globe which are expected to be impacted by Alzheimer’s disease by 2030
- Companies
AssetCo acquires 63% stake in Rize ETF for £16.5m
The 63% acquisition will see a further investment of £5.25m to help fund the growth of the business
- News
UK Pharmaceutical Company’s $130m Punt On French Cannabis Patent
PHARMACEUTICAL company Indivior is expanding into medicines for cannabis-related disorders.
